Related Experiment Video
Updated: Jul 16, 2026
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
A perspective of monoclonal antibodies: past, present, and future
1Health Science Center, Veterans Administration Medical Center, Syracuse, NY 13210.
Abstract:
In 1975, the development of the technique to produce monoclonal antibodies revolutionized the approach to cancer detection and therapy. Hundreds of monoclonal antibodies to the epitopes of tumor cells have been produced, providing more specific tools for probing the cellular elements of cancer. At the same time, these tools have disclosed greater complexity in the character of these cells and stimulated further investigation. Although there are antibodies to specific epitopes of neoplastic cells, this purity has not provided the improved detection and therapy of cancer first expected. Technical manipulations have provided limited improvement in results, but more sophisticated techniques, such as biologic response modifiers, may be required to attain clinical results that can be universally applied. The intense research in monoclonal antibodies and their application does offer promise that the goal of improved cancer detection and therapy will be forthcoming.
Insights
Monoclonal antibodies revolutionized cancer research, offering specific tools for detection and therapy. While challenges remain, ongoing research promises improved cancer diagnostics and treatments.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- The development of monoclonal antibodies in 1975 significantly advanced cancer detection and therapy.
- Monoclonal antibodies provide specific tools for analyzing tumor cell epitopes, revealing cellular complexity.
Purpose of the Study:
- To review the impact and limitations of monoclonal antibodies in cancer detection and therapy.
- To explore the future potential of advanced techniques in cancer treatment.
Main Methods:
- Production of monoclonal antibodies targeting specific tumor cell epitopes.
- Analysis of the complexity of neoplastic cells using these antibodies.
- Evaluation of technical manipulations and advanced therapeutic strategies.
Main Results:
- Monoclonal antibodies offer enhanced specificity for cancer cell analysis.
- Despite specificity, expected improvements in cancer detection and therapy have been limited.
- Further research indicates potential for advanced techniques like biologic response modifiers.
Conclusions:
- Monoclonal antibodies have transformed cancer research but require further refinement for universal clinical application.
- Advanced techniques are crucial for achieving significant clinical breakthroughs in cancer treatment.
- Continued intensive research in monoclonal antibodies holds promise for future advancements in cancer care.
Related Concept Videos
00:42Cross-reactivity
01:10Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:31Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:25Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
01:26Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:29Microorganisms in Medicine and Therapeutics